Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 04, 2026 01:00 ET | Source: Molecular Partners

Molecular Partners to hold oral presentations on DLL3-targeting Radio-DARPin candidate MP0712 at multiple upcoming scientific conferences

ZURICH-SCHLIEREN, Switzerland and Concord, Mass., May 04, 2026 (GLOBE NEWSWIRE) -- Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a novel class of...
May 01, 2026 07:00 ET | Source: Molecular Partners

Molecular Partners publishes Phase 1 MP0317 data in Nature Cancer demonstrating tumor-localized CD40 activation and tumor microenvironment remodeling

Positive Phase 1 data confirm MP0317’s tumor-localized CD40 activation with a favorable safety profile in patients with advanced cancer typesPharmacokinetic profile of MP0317 well suited for...
April 30, 2026 16:54 ET | Source: Wisekey International Holding Ltd.

WISeKey Reports Audited Full Year 2025 Financial Results

WISeKey Reports Audited Full Year 2025 Financial Results Schedules Conference Call for Monday, May 4 at 9:00am EDT Audited FY 2025 revenue of $19.3 million, representing 62% growth...
April 30, 2026 07:00 ET | Source: Novartis Pharma AG

Novartis finalizes US manufacturing and R&D expansion plan with seventh new facility

At one-year mark, company has progressed all components of US investment plan to support delivery of innovative medicines to US patientsNew active pharmaceutical ingredients facility in North Carolina...
April 30, 2026 07:00 ET | Source: Novartis Pharma AG

Novartis finalizes US manufacturing and R&D expansion plan with seventh new facility

At one-year mark, company has progressed all components of US investment plan to support delivery of innovative medicines to US patientsNew active pharmaceutical ingredients facility in North Carolina...
April 30, 2026 03:00 ET | Source: 21Shares

21shares Partners with Kaiko Indices to Enhance Pricing Precision Across European Single-Asset Crypto Suite

Zurich, 30 April 2026 – 21shares, a global leader in cryptocurrency exchange-traded products (ETPs), has successfully transitioned the underlying index provider for a broad segment of its European...
April 30, 2026 01:00 ET | Source: Santhera Pharmaceuticals Holding AG

Santhera Proposes Dr. Srishti Gupta as New Member of the Board of Directors

Ad hoc announcement pursuant to Art. 53 LR. Pratteln, Switzerland, April 30, 2026 – Santhera Pharmaceuticals (SIX: SANN) proposes to elect Dr. Srishti Gupta, MD, MPP, MPhil, as an Independent...
April 30, 2026 01:00 ET | Source: Santhera Pharmaceuticals Holding AG

Santhera schlägt Dr. Srishti Gupta als neues Mitglied des Verwaltungsrats

Ad-hoc-Mitteilung gemäss Art. 53 KR. Pratteln, Schweiz, 30. April 2026 – Santhera Pharmaceuticals (SIX: SANN) schlägt vor, Dr. Srishti Gupta, MD, MPP, MPhil, auf der bevorstehenden ordentlichen...
April 30, 2026 01:00 ET | Source: F. Hoffmann-La Roche Ltd

Roche to present extensive data showcasing its industry-leading ophthalmology portfolio at ARVO 2026

New real-world data confirm Vabysmo’s potent retinal drying in nAMD and DMEKey data for Susvimo demonstrate its potential to provide lasting disease control through continuous delivery, while reducing...
April 30, 2026 01:00 ET | Source: Addex Therapeutics

Addex Reports Full Year 2025 Financial Results and Provides Corporate Update

GABAB PAM chronic cough candidate continued towards clinic after demonstrating robust anti-tussive activity in multiple disease modelsContinued to reposition dipraglurant mGlu5 NAM for brain injury...